Store-Operated Ca²⁺ Entry Does Not Control Proliferation in Primary Cultures of Human Metastatic Renal Cellular Carcinoma

Table 1

Clinical characteristics of renal cellular carcinoma patients involved in this study.

Patient	Sex	Day of birth	Year of diagnosis	Histology	Stage^1 at diagnosis	Surgery for localized disease	Systemic treatments received
LA	M	14/11/1944	1995	Clear cell RCC	pT2, Nx, M0	Yes, radical nephrectomy	IL-2; Sorafenib; Sunitinib; Everolimus; Experimental vaccine
DPV	M	21/05/1953	2010	Bellini’s duct RCC	pT2, N2, M1	Yes. Radical nephrectomy	Temsirolimus; Sorafenib; Sunitinib; Cytotoxic chemotherapy; Experimental vaccine
LG	F	25/12/1948	2005	Clear cell RCC	pT2, N0, M0	Yes. Partial nephrectomy	Cytotoxic chemotherapy; Sunitinib; Everolimus; Sorafenib; Interferon-𝛼; Experimental vaccine
GG	M	20/10/1959	2009	Papillary type I RCC	pT3b, N0, M1	Yes, radical nephrectomy	Sunitinib; Sorafenib; Everolimus; Cytotoxic chemotherapy; Experimental vaccine

1Stage is indicated according to the 2002 TNM staging system.